SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-008820
Filing Date
2017-02-08
Accepted
2017-02-08 17:36:08
Documents
1
Period of Report
2017-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3505
  Complete submission text file 0001209191-17-008820.txt   4906
Mailing Address 12481 HIGH BLUFF DRIVE, SUITE 160 SAN DIEGO CA 92130
Business Address
Turner Heather D (Reporting) CIK: 0001403571 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36548 | Film No.: 17583662

Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences